For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251208:nRSH6974Ka&default-theme=true
RNS Number : 6974K Seed Innovations Limited 08 December 2025
Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments
REACH Announcement
8 December 2025
SEED Innovations Ltd
("SEED" or the "Company")
Investor Presentation Notification
Introduction to Newly Appointed Directors
SEED Innovations Ltd, the AIM quoted investment company, is pleased to
announce that it will host an investor presentation on 11 December 2025 at
12.30pm via the Investor Meet Company platform to introduce its newly
appointed directors: Jim Mellon, Denham Eke, and Sir James Bucknall.
Shareholders who wish to attend should register in advance using the following
link:
https://www.investormeetcompany.com/seed-innovations-limited/register-investor
(https://www.investormeetcompany.com/seed-innovations-limited/register-investor)
Investors who already follow SEED Innovations Ltd on the Investor Meet Company
platform will receive an automatic invitation.
Please note that no questions will be taken during this introductory meeting.
The Company intends to hold a more in depth session early in the New Year on
the platform, focused on its new investing strategy in humanoid robotics and
associated artificial intelligence (AI), where investors will have the
opportunity to submit questions.
- Ends -
For further information, visit: www.seedinnovations.co
(http://www.seedinnovations.co/) or contact:
Lance de Jersey SEED Innovations Ltd E: info@seedinnovations.co
James Biddle Beaumont Cornish Limited T: (0)20 7628 3396
Roland Cornish Nomad
Isabella Pierre Shard Capital Partners LLP T: (0)20 7186 9927
Damon Heath Broker
Ana Ribeiro St Brides Partners Ltd E: seed@stbridespartners.co.uk
Isabel de Salis Financial PR
Seb Weller
NOTES
Seed Innovations Ltd
SEED Innovations Ltd (SEED.L) is an AIM-quoted investment company focused on
providing access to high-growth robotics and AI ventures typically beyond the
reach of everyday investors. The Company also oversees a legacy portfolio in
wellness and life sciences, with a medium-term strategy to unlock its full
value. Back by an experienced team and strong cash reserves, the Company
remains agile and well-positioned to capitalise on new investment
opportunities as they arise.
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAUWASRVBUURAA
Copyright 2019 Regulatory News Service, all rights reserved